Biology 9700 · AS & A Level · Genetic technology applied to medicine

Genetic technology applied to medicine — practice question

Many tumours secrete a protein growth factor known as VEGF. This acts as a chemical messenger that makes nearby blood vessels form fresh branches into the tumour. The monoclonal antibody bevacizumab (Avastin®) binds specifically to VEGF.
(a)[2]

Suggest how Avastin® can stop a tumour from growing and spreading.

(b(i))[1]

State the antigen that is injected into a mouse in order to produce this monoclonal antibody.

(b(ii))[1]

State what is meant by a hybridoma.

(c)[3]

The monoclonal antibody made by the hybridoma method is altered to produce a humanised mouse antibody. This kind of antibody molecule is similar to those made by humans. Suggest advantages of using humanised mouse antibody rather than mouse antibody.

(d)[2]

A second monoclonal antibody, ranibizumab (Lucentis®), is used to treat eye disease. Lucentis® is a fragment of Avastin® and is shown in Fig. 2.1. Complete Fig. 2.1 so that it shows a molecule of Avastin®. Labels are not required.

Worked solution & mark scheme

This 9-mark question has a full step-by-step worked solution and mark scheme. One marking point: blocks the formation of new blood vessels to the tumour

  • Full mark scheme, point by point
  • Step-by-step worked solution
  • Write your answer & get it marked instantly by AI